| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.37 | $1.16 | $1.42 | $1.18 | $0.99 | $0.92 |
| EPS (Diluted) | $1.37 | $1.16 | $1.42 | $1.17 | $0.99 | $0.92 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $3.1B | $3.1B | $3.1B | $3.2B | $2.6B | $2.0B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.8B | $0.4B | $0.1B |
| Total Liabilities | $2.8B | $2.8B | $2.8B | $2.9B | $2.4B | $1.7B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.1B | $-0.0B | $-0.4B | $-0.3B | $-0.3B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.0B | $-0.1B | $0.6B | $0.6B | $0.1B |